Executive Director, Investor RelationsRevolution Medicinesfull-timeAbout Revolution MedicinesDeveloping precision oncology therapies for RAS-addicted cancersThis page is fully interactive when JavaScript is enabled. Please enable JavaScript to apply or browse related roles.